NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2052210134

Registered date:17/12/2021

Clinical Trial of POD T 49P

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedCataract
Date of first enrollment17/12/2021
Target sample size56
Countries of recruitment
Study typeInterventional
Intervention(s)Perform cataract surgery and implant an intraocular lens; POD T 49P in the aphakic eye.

Outcome(s)

Primary OutcomeUncorrected visual acuity at Visit 4 Manifest Cylinder power at Visit 4
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteria- Subject with corneal astigmatism - Target postoperative refraction is emmetropia
Exclude criteria- Subjects with diseases that affect postoperative visual acuity in the cornea or retina - Irregular corneal aberration - Poor mydriasis - Previous refractive surgery - Other protocol-defined exclusion criteria may apply.

Related Information

Contact

Public contact
Name Tsunemitsu Senta
Address 2-8 Kojimachi, Chiyoda-ku, Tokyo Tokyo Japan 102-0083
Telephone +81-3-5214-2277
E-mail tsenta@bvimedical.com
Affiliation BVI Japan
Scientific contact
Name Hiroko Bissen Miyajima
Address 2-9-18 Kanda-Misakicho, Chiyoda-ku, Tokyo Tokyo Japan 101-0061
Telephone +81-3-5275-1856
E-mail bissen@tdc.ac.jp
Affiliation Tokyo Dental College Suidobashi Hospital